Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
The Journal of Rheumatology
|
November 18, 1998
IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus
M Samarkos, K Davies, S Loizou
The Journal of Rheumatology
|
May 1, 2001
The clinical significance of IgA antiphospholipid antibodies
M Samarkos, R A Asherson, S Loizou
Hippokratia
|
August 8, 2022
Abdominal aorta aneurysm endograft infection mimicking bacteraemic urinary tract infection
N Papazoglou, M Samarkos, C Vergadis, et al.
Clinical Rheumatology
|
August 11, 2005
Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
M Samarkos, K A Davies, C Gordon, et al.
Critical Reviews in Clinical Laboratory Sciences
|
April 25, 2007
Antiphospholipid antibodies: laboratory and pathogenetic aspects
P G Vlachoyiannopoulos, M Samarkos, M Sikara, et al.
Seminars in Arthritis and Rheumatism
|
June 14, 2008
Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics
E Mylona, M Samarkos, E Kakalou, et al.
Hippokratia
|
February 12, 2011
Pasteurella multocida bacteremia, spontaneous bacterial peritonitis and septic arthritis in a cirrhotic patient
M Samarkos, P Fanourgiakis, I Nemtzas, et al.
Scandinavian Journal of Gastroenterology
|
May 10, 2003
Association of protein-losing enteropathy and cryoglobulinaemia
M Samarkos, G Vaiopoulos, A Andreopoulos, et al.
Rheumatology (Oxford, England)
|
September 19, 2001
IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations
M Samarkos, K A Davies, C Gordon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 19, 2018
The 3-day rule for stool cultures: should all patients with haematological malignancies be excluded?
M Samarkos, O Kampouropoulou, V Theofanis, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
The Journal of Rheumatology
|
November 18, 1998
IgA class anti-beta2-glycoprotein I in patients with systemic lupus erythematosus
M Samarkos, K Davies, S Loizou
The Journal of Rheumatology
|
May 1, 2001
The clinical significance of IgA antiphospholipid antibodies
M Samarkos, R A Asherson, S Loizou
Hippokratia
|
August 8, 2022
Abdominal aorta aneurysm endograft infection mimicking bacteraemic urinary tract infection
N Papazoglou, M Samarkos, C Vergadis, et al.
Clinical Rheumatology
|
August 11, 2005
Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome
M Samarkos, K A Davies, C Gordon, et al.
Critical Reviews in Clinical Laboratory Sciences
|
April 25, 2007
Antiphospholipid antibodies: laboratory and pathogenetic aspects
P G Vlachoyiannopoulos, M Samarkos, M Sikara, et al.
Seminars in Arthritis and Rheumatism
|
June 14, 2008
Pyogenic vertebral osteomyelitis: a systematic review of clinical characteristics
E Mylona, M Samarkos, E Kakalou, et al.
Hippokratia
|
February 12, 2011
Pasteurella multocida bacteremia, spontaneous bacterial peritonitis and septic arthritis in a cirrhotic patient
M Samarkos, P Fanourgiakis, I Nemtzas, et al.
Scandinavian Journal of Gastroenterology
|
May 10, 2003
Association of protein-losing enteropathy and cryoglobulinaemia
M Samarkos, G Vaiopoulos, A Andreopoulos, et al.
Rheumatology (Oxford, England)
|
September 19, 2001
IgG subclass distribution of antibodies against beta(2)-GP1 and cardiolipin in patients with systemic lupus erythematosus and primary antiphospholipid syndrome, and their clinical associations
M Samarkos, K A Davies, C Gordon, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases
|
July 19, 2018
The 3-day rule for stool cultures: should all patients with haematological malignancies be excluded?
M Samarkos, O Kampouropoulou, V Theofanis, et al.
Page
of 3